MedTrace Logo

Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes

NCT06361641 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-12-08

No results posted yet for this study

Summary

Prospective study for functional and phenotypic characterization of monocytes in philadelphia-negative myeloproliferative neoplasms

Conditions

  • Myeloproliferative Neoplasm
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Primary Myelofibrosis

Interventions

DIAGNOSTIC_TEST

Monocytes signatures in myeloproliferative neoplasms at diagnosis

The monocytes signatures will be perform from a peripheral blood sample. The signature will be derived from (i) surface marker expression, (ii) cytokines profiles, (iii) genes expression.

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Agathe GOUBAND, PharmD · University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-29
Primary Completion
2026-10-19
Completion
2028-10-19

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06361641 on ClinicalTrials.gov